This highlights the fact that TPD53 and TPD52 are positive regulators of Akt signaling in low-malignant cells [26,27,28], suggesting that TPD53 can enhance the proliferative and invasive potential of cancer cells by increasing MMP activity via the Akt pathway. Here, AKT1 is linked to cancer.